Latest Oncology Stories
- Data Show Significant Survival Improvement with CPX-351 in Poor-Risk Patients - EWING, N.J., Jan. 12, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
MANHATTAN BEACH, Calif., Jan.
The Oncology Institute of Hope and Innovation announces first clinical trial of the year. Downey, CA (PRWEB) January 10, 2015 The Oncology Institute
Aldoxorubicin Showed 66% Complete or Partial Responses and No Tumor Progression in KS Patients with Excellent Tolerability LOS ANGELES, Jan.
A special one-day track for non-clinically licensed oncology patient navigators will be offered at the Academy of Oncology Nurse & Patient Navigators’ (AONN+) Sixth Annual Navigation and
Susan G. Komen® Central and Northern Arizona (Komen CAN AZ) will tackle breast cancer by raffling two tickets for the Big Game occurring in Glendale, Arizona on February 1, 2015.
The Mesothelioma Victims Center is launching a new campaign focused on providing instant access to the nation's best mesothelioma compensation lawyers for all US Navy Veterans exposed to asbestos while